Yale University

Naltrexone Helps HIV Positive Individuals Reduce Heavy Alcohol Use

Extended-release naltrexone - an injection that decreases heavy drinking in the general population when taken in conjunction with counseling - appears to help HIV-positive individuals reduce their number of heavy drinking days too, say Yale researchers.

"While we know that patients with heavy alcohol use are less likely to take their medications for HIV, there is a paucity of interventions that target alcohol use to improve how patients take their medications," said Jennifer Edelman, M.D., first author and associate professor at the Yale School of Medicine. "Extended-release naltrexone is a medication that is safe and effective for patients living with HIV that can be delivered in HIV treatment settings that could potentially help this problem."

More from YaleNews



Published: Sunday, August 12, 2018